Progenitor cell-based treatment of the pediatric myelin disorders

Archives of Neurology

Volumn 68, Issue 7, 2011, Pages 848-856

  Goldman, Steven A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ASTROCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CONGENITAL HYPOMYELINATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODEL; EMBRYONIC STEM CELL; ENZYME DEFICIENCY; GLIA CELL; HUMAN; LEUKODYSTROPHY; LYSOSOME STORAGE DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLIC DISORDER; MYELINATION; NERVE FIBER; NEURAL STEM CELL; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; OLIGODENDROGLIA; PEDIATRIC MYELIN DISORDER; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; DEMYELINATING DISEASES; HUMANS; NEUROGLIA; NEURONS; PEDIATRICS; STEM CELLS; TISSUE THERAPY;

EID: 79956200918     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.46     Document Type: Review

References (68)

1. Goldman SA. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol. 2005;23(7):862-871.
2. Goldman SA, Windrem MS. Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci. 2006;361(1473):1463-1475. (Pubitemid 44450205)
3. Koch P, Kokaia Z, Lindvall O, Brüstle O. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol. 2009;8(9):819-829.
4. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders: time for clinical translation? J Clin Invest. 2010;120(1):29-40.
5. Martino G, Franklin RJ, Van Evercooren AB, Kerr DA; Stem Cells in Multiple Sclerosis (STEMS) Consensus Group. Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol. 2010;6(5):247-255.
6. Jakel RJ, Schneider BL, Svendsen CN. Using human neural stem cells to model neurological disease. Nat Rev Genet. 2004;5(2):136-144. (Pubitemid 38160280)
7. Gage FH. Mammalian neural stem cells. Science. 2000;287(5457):1433-1438. (Pubitemid 30127128)
8. Goldman SA. Adult neurogenesis: from canaries to the clinic. J Neurobiol. 1998; 36(2):267-286. (Pubitemid 28363236)
9. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97(26):14720-14725. (Pubitemid 32016642)
10. Keyoung HM, Roy NS, Benraiss A, et al. High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Nat Biotechnol. 2001;19(9):843-850. (Pubitemid 32816754)
11. Roy NS, Benraiss A, Wang S, et al. Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. J Neurosci Res. 2000;59(3):321-331. (Pubitemid 30107971)
12. Pincus DW, Keyoung HM, Harrison-Restelli C, et al. Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann Neurol. 1998;43(5):576-585. (Pubitemid 28225548)
13. Pincus DW, Harrison-Restelli C, Barry J, et al. In vitro neurogenesis by adult human epileptic temporal neocortex. Clin Neurosurg. 1997;44:17-25.
14. Arsenijevic Y, Villemure JG, Brunet JF, et al. Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol. 2001;170(1):48-62. (Pubitemid 32641773)
15. Windrem MS, Nunes MC, Rashbaum WK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med. 2004;10(1):93-97. (Pubitemid 38524704)
16. Roy NS, Wang S, Harrison-Restelli C, et al. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci. 1999;19(22):9986-9995. (Pubitemid 30226670)
17. Nunes MC, Roy NS, Keyoung HM, et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9(4):439-447. (Pubitemid 36460078)
18. Belachew S, Chittajallu R, Aguirre AA, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol. 2003;161(1):169-186. (Pubitemid 36459089)
19. Noble M, Wren D, Wolswijk G. The O-2A(adult) progenitor cell: a glial stem cell of the adult central nervous system. Semin Cell Biol. 1992;3(6):413-422.
20. Windrem MS, Roy NS, Wang J, et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res. 2002;69(6):966-975. (Pubitemid 34984714)
21. Duncan ID, Grever WE, Zhang SC. Repair of myelin disease: strategies and progress in animal models. Mol Med Today. 1997;3(12):554-561. (Pubitemid 28022795)
22. Archer DR, Cuddon PA, Lipsitz D, Duncan ID. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nat Med. 1997;3(1):54-59. (Pubitemid 27019141)
23. Yandava BD, Billinghurst LL, Snyder EY. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A. 1999;96(12):7029-7034. (Pubitemid 29275004)
24. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374(6520):367-370.
25. Lee J-P, Jeyakumar M, Gonzalez R, et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med. 2007;13(4):439-447. (Pubitemid 46559825)
26. Garbern J, Cambi F, Shy M, Kamholz J. The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol. 1999;56(10):1210-1214. (Pubitemid 29473212)
27. Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol. 2001;24(1):11-24. (Pubitemid 32140931)
28. Kumar S, Mattan NS, de Vellis J. Canavan disease: a white matter disorder. Ment Retard Dev Disabil Res Rev. 2006;12(2):157-165.
29. van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5(5):413-423.
30. van der Knaap MS, Lai V, Köhler W, et al. Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann Neurol. 2010;67(6):834-837.
31. Leegwater PA, Yuan BQ, van der Steen J, et al. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet. 2001;68(4):831-838. (Pubitemid 32289728)
32. Powers J. The leukodystrophies: overview and classification. In: Lazzarini RA, ed. Myelin Biology and Disorders. Vol 2. San Diego, CA: Elsevier Academic Press; 2004:663-690.
33. Back SA, Rivkees SA. Emerging concepts in periventricular white matter injury. Semin Perinatol. 2004;28(6):405-414. (Pubitemid 40037567)
34. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004;24(18):4412-4420. (Pubitemid 38608152)
35. Robinson S, Petelenz K, Li Q, et al. Developmental changes induced by graded prenatal systemic hypoxic-ischemic insults in rats. Neurobiol Dis. 2005;18(3):568-581. (Pubitemid 40332715)
36. Levison SW, Rothstein RP, Romanko MJ, Snyder MJ, Meyers RL, Vannucci SJ. Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci. 2001;23(3):234-247. (Pubitemid 34701678)
37. Lachapelle F, Gumpel M, Baumann N. Contribution of transplantations to the understanding of the role of the PLP gene. Neurochem Res. 1994;19(8):1083-1090. (Pubitemid 24243345)
38. Lachapelle F, Gumpel M, Baulac M, Jacque C, Duc P, Baumann N. Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I: immunohistochemical studies. Dev Neurosci. 1983-1984-1984;6(6):325-334. (Pubitemid 15051599)
39. Mitome M, Low HP, van den Pol A, et al. Towards the reconstruction of central nervous system white matter using neural precursor cells. Brain. 2001;124(pt 11):2147-2161. (Pubitemid 33055360)
40. Windrem MS, Schanz SJ, Guo M, et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell. 2008;2(6):553-565. (Pubitemid 351729215)
41. Windrem MS, Roy N, Nunes M, Goldman SA. Identification, selection and use of adult human oligodendrocyte progenitor cells. In: Zigova T, Snyder E, eds. Neural Stem Cells for Brain Repair. New York, NY: Humana; 2003:69-88.
42. Roy N, Windrem M, Goldman SA. Progenitor cells of the adult white matter. In: Lazzarini R, ed. Myelin Biology and Disorders. Amsterdam, the Netherlands: Elsevier; 2004:259-287.
43. Keyoung HM, Goldman SA. Glial progenitor-based repair of demyelinating neurological diseases. Neurosurg Clin N Am. 2007;18(1):93-104. (Pubitemid 46161194)
44. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol. 2003;18(9):595-603. (Pubitemid 37258464)
45. Urayama A, Grubb JH, Sly WS, Banks WA. Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci U S A. 2004;101(34):12658-12663. (Pubitemid 39122079)
46. Jeyakumar M, Dwek RA, Butters TD, Platt FM. Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci. 2005;6(9):713-725. (Pubitemid 44773245)
47. Lacorazza HD, Flax JD, Snyder EY, Jendoubi M. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med. 1996;2(4):424-429. (Pubitemid 26191914)
48. Pellegatta S, Tunici P, Poliani PL, et al. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/ microglia activation. Neurobiol Dis. 2006;21(2):314-323. (Pubitemid 43099855)
49. Pluchino S, Furlan R, Martino G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr Opin Neurol. 2004;17(3):247-255. (Pubitemid 38720975)
50. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003;422(6933):688-694. (Pubitemid 36514101)
51. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352(20):2069-2081. (Pubitemid 40664308)
52. Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30(4):215-222. (Pubitemid 35023593)
53. Givogri MI, Galbiati F, Fasano S, et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci. 2006;26(12):3109-3119.
54. Gentner B, Visigalli I, Hiramatsu H, et al. Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med. 2010;2(58):58ra84.
55. Selden NR, Guillaume DJ, Steiner RD, Huhn SL. Cellular therapy for childhood neurodegenerative disease, part II: clinical trial design and implementation. Neurosurg Focus. 2008;24(3-4):E23.
56. Tamaki S, Eckert K, He D, et al. Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res. 2002;69(6):976-986. (Pubitemid 34984715)
57. Tamaki SJ, Jacobs Y, Dohse M, et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell. 2009;5(3):310-319.
58. Nistor GI, Totoiu MO, Haque NS, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49(3):385-396. (Pubitemid 40222916)
59. Brüstle O, Jones KN, Learish RD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999;285(5428):754-756.
60. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12(11):1259- 1268. (Pubitemid 44706928)
61. Belmonte JC, Ellis J, Hochedlinger K, Yamanaka S. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet. 2009;10(12):878-883.
62. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010;24(20):2239-2263.
63. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007;1(1):39-49. (Pubitemid 46865811)
64. Yamanaka S. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008;363(1500):2079-2087. (Pubitemid 351693523)
65. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676. (Pubitemid 44233629)
66. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007;2(12):3081-3089.
67. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.
68. Wernig M, Zhao J-P, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008;105(15):5856-5861. (Pubitemid 351758462)